Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DB25FH81L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,965
Award facts
- Contract value 100% obligated
- $7,964.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a pharmaceutical product commonly used for nausea and vomiting management in clinical and military healthcare settings. Valued at $7,964.61 with a firm fixed price structure, this non-set-aside competitive award was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive IDC vehicle that supports global pharmaceutical supply needs. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's role in supporting DLA's medical supply chain through competitively awarded transactions with consistent firm fixed pricing, enabling the company to fulfill federal medical procurement requirements across multiple therapeutic domains and customer bases.
Quick answers
Who was awarded contract SPE2DB25FH81L?
SPE2DB25FH81L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FH81L worth?
The government has obligated $7,965 on SPE2DB25FH81L.
Is contract SPE2DB25FH81L an order under another contract?
Yes. SPE2DB25FH81L is a delivery order under SPE2DB20D1050, an indefinite delivery contract.
Was contract SPE2DB25FH81L competed?
The extent of competition for SPE2DB25FH81L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award